Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 7/04/2014 → 31/05/2021 |
Collaborative partners
- King's College London (lead)
- Centre for Addiction and Mental Health
- Greater Glasgow Health Board
- Novartis Horsham Research Centre
- Sanquin Blood Supply Foundation
- GSTT Guy's and St Thomas' NHS Foundation Trust
- University of Liverpool
- University of Manchester
- Newcastle University
- Janssen Research & Development LLC
- Becton, Dickinson & Company
- AbbVie Inc.
- Celgene Ltd
- MedImmune LLC
- Pfizer Inc.
- Psoriasis Association
- Qiagen Manchester Ltd
- Queen Mary University of London
- Stiefel Laboratories Inc.
Funding
- MRC Medical Research Council: £6,000.00
- MRC Medical Research Council: £75,137.05
- MRC Medical Research Council: £122,809.32
- MRC Medical Research Council: £1,822,881.00
- MRC Medical Research Council: £93,155.57
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.